Navigation Links
Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Date:4/30/2008

OMAHA, Neb., April 30 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a global genetic analysis and services company, today announced the National Cancer Institute had approved a proposal to perform mutational analysis and sequencing of the mitochondrial genes in the NCI 60 cancer cell line panel.

Mitochondrial damage is increasingly recognized as an early warning signal in several different types of cancer. This is the first comprehensive evaluation of the mitochondrial genome in the NCI 60 panel. The data from this study will be a valuable tool for integrating mitochondrial genomics with other data derived from the NCI 60 panel.

"Tens of thousands of compounds have been tested against the NCI 60 cell lines in the NCI's pharmacological database of cancer drugs," chief scientific officer Dr. Eric Kaldjian described. "This collaboration makes it possible to test whether in vitro responses to anti-cancer agents are linked to alterations in the mitochondrial genome and can be detected with our sensitive mutation detection technology."

Chief executive officer Craig Tuttle remarked, "Over the last 2 years, we have grown our laboratory services business focusing on diseases associated with mitochondrial DNA. As we learn more about the mitochondria and its role in disease, we are finding that mitochondrial mutation testing can provide diagnostic insights earlier in the disease process giving physicians early warning signals they can use to monitor at risk patients or even begin therapy. This study is an important milestone for the company and will further validate our leadership in the analysis of the mitochondrial genome in disease. The NCI 60 panel study further demonstrates Transgenomic's expertise in the evolving area of diagnostic testing for mitochondrial mutations."

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services of automated high sensitiv
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
4. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... NEW YORK , Nov. 20, 2014  Market research ... as the "Year of The Buy, in the medical ... market for medical devices will produce just 3% growth ... competitive actions, including acquisitions of product lines and entrance ... an annual survey of medical devices, The Global ...
(Date:11/21/2014)...  The acceptance of two abstracts on the ... demonstrates continued interest in the Eclipse System, the ... of the abstracts, presented by Catherine Matthews ... Urogynecology and Reconstructive Pelvic Surgery at the University ... Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... Nov. 20, 2014 Oxis International, Inc. (OXIS) (OXI.PA) ... election of Anthony J. Cataldo as Chief Executive ... Effective November 19, 2014, Ken Eaton resigned his ... of Directors of Oxis International, Inc. to pursue new opportunities. ... named Chief Executive Officer of Oxis International, Inc. Mr. Cataldo ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... Feb. 18, 2011 Zimmer Holdings, Inc. (NYSE: ... announced it has received FDA clearance for the TM-S ... is the industry,s first cervical interbody device incorporating porous metal ... for cervical interbody fusion (IBF) in the United States. ...
... CARLSBAD, Calif., Feb. 18, 2011 Life Technologies Corporation ... Angel Carracedo and Dr. Mark Pallen as the winners of ... Grants Program.   (Logo:   http://photos.prnewswire.com/prnh/20110216/MM49339LOGO ) ... because of the ubiquitous nature of the Ion Torrent sequencing ...
Cached Medicine Technology:Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 2Zimmer Spine Introduces Industry's First Porous Metal Cervical Interbody Device 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 2Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 3Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 4Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe 5
(Date:11/22/2014)... (PRWEB) November 22, 2014 Hastings and ... decades of experience announces providing clients with the option ... firm offers clients a flexible, intuitive and easy to ... with having access to Google + allows clients to ... to make a more informed decision when retaining an ...
(Date:11/22/2014)... FL (PRWEB) November 22, 2014 ... Innovations are pleased to announce that Ashley Lombardo ... Thanksgiving #PayItForward contest. , Ms. Lombardo entered friend ... Kitchen Innovations. She wrote of how her friend is ... daughters as a single mom. Despite medical bills piling ...
(Date:11/22/2014)... Boulder, CO (PRWEB) November 22, 2014 ... on growth equity investments in the consumer brand ... LLC. The investment will be used to help ... new product pipeline rollout, particularly its proprietary apparel ... Suslow will join BackJoy’s Board of Directors. , ...
(Date:11/22/2014)... Aliso Viejo, California (PRWEB) November 22, 2014 ... have announced a new plugin entitled FCPX 3D Model bringing ... , “FCPX 3D Model allows users to add obj files ... of Pixel Film Studios. “Blurring the line between professional and ... FCPX3D Model from Pixel Film Studios allows Final Cut Pro ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... Assam and Tripura have warned people against eating fish// ... saying the long time taken in transit rendered the ... ,The warning follows a report by the ... husks gets contaminated during the eight to 10 day ...
... Medical Journal report says that staff shortages in radiotherapy units ... and thus reducing their chances of surviving the condition. ... those in most developed countries and indeed many poorer countries," ... BMJ report. "Unfortunately the here and now of this is ...
... Ontario Government to launch a programme to ensure provision ... assault, who might have been exposed to the HIV/AIDS ... ($1,200) has resulted in a limited availability of this ... ,Very little effort is being done to promote ...
... the Health Minister of the Indian State of Bihar has announced ... introduced// in the state. An annual premium of Rs 250 will ... This will serve to provide the family with free health services ... the poverty line will receive the benefits without having to pay ...
... therapy is being provided to people who wish to give ... are over the age of 18 years// will benefit from ... Treatment for Ontario Patients (STOP) Study, which will also provide ... to which quitting method is more effective, according to Center ...
... transfer technology to generic drug manufacturers in the ... versions of the HIV drug saquinavir. ... Roche has announced further expansion of its current ... Developed Countries by providing local manufacturers with the ...
Cached Medicine News:Health News:Reach Of The Morning-After Pill Treatment Inadequate Among Sexual Assault Victims 2Health News:Roche offers HIV drug expertise to poor nations 2
Replacement bulb for Vibratome light system....
Injector blades come ten to an injector and allow for the easy replacement of Vibratome cutting blades....
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
Medicine Products: